FCGCX
Price
$20.48
Change
+$0.06 (+0.29%)
Updated
Sep 5 closing price
Net Assets
895.5M
TRNEX
Price
$41.36
Change
+$0.11 (+0.27%)
Updated
Sep 8 closing price
Net Assets
2.39B
Interact to see
Advertisement

FCGCX vs TRNEX

Header iconFCGCX vs TRNEX Comparison
Open Charts FCGCX vs TRNEXBanner chart's image
Fidelity Advisor Global Commodity Stk C
Price$20.48
Change+$0.06 (+0.29%)
VolumeN/A
Net Assets895.5M
T. Rowe Price New Era I
Price$41.36
Change+$0.11 (+0.27%)
VolumeN/A
Net Assets2.39B
FCGCX vs TRNEX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
FCGCX vs. TRNEX commentary
Sep 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FCGCX is a Hold and TRNEX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
TRNEX has more cash in the bank: 2.4B vs. FCGCX (895M). TRNEX pays higher dividends than FCGCX: TRNEX (2.06) vs FCGCX (1.20). FCGCX was incepted earlier than TRNEX: FCGCX (16 years) vs TRNEX (10 years). FCGCX (1.90) is less costly to investors than TRNEX (0.57). FCGCX is a more actively managed with annual turnover of: 49.00 vs. TRNEX (24.30). FCGCX has a lower initial minimum investment than TRNEX: FCGCX (0) vs TRNEX (500000). FCGCX annual gain was more profitable for investors over the last year : 14.21 vs. TRNEX (7.74). FCGCX return over 5 years is better than : 92.93 vs. TRNEX (59.99).
FCGCXTRNEXFCGCX / TRNEX
Total Expense Ratio1.900.57333%
Annual Report Gross Expense Ratio1.900.57333%
Fund Existence16 years10 years-
Gain YTD14.41311.156129%
Front LoadN/AN/A-
Min. Initial Investment0500000-
Min. Initial Investment IRA500N/A-
Net Assets895M2.4B37%
Annual Yield % from dividends1.202.0658%
Returns for 1 year14.217.74184%
Returns for 3 years14.9013.04114%
Returns for 5 years92.9359.99155%
Returns for 10 years116.05N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
KYTX3.940.31
+8.54%
Kyverna Therapeutics
BMA58.910.69
+1.19%
Banco Macro SA
DXCM80.51-0.25
-0.31%
DexCom
AMS2.51-0.04
-1.57%
American Shared Hospital Services
CAPL20.56-0.44
-2.10%
CrossAmerica Partners LP